Medicaid Program Integrity: Tracking State-Specific and Nationwide Federal Action
This page tracks emerging developments in the federal government’s approach to Medicaid program integrity, along…
Medicaid Program Integrity: Tracking State-Specific and Nationwide Federal Action
This page tracks emerging developments in the federal government’s approach to Medicaid program integrity, along with the implications of those actions for different states.
Opioid Settlement Money Pays for Services To Battle Addiction in Rural Kentucky
WHITESBURG, Ky. — Drugs and the consequences of addiction are woven into the fabric of Jamie Madden’s life. Her earliest memory is of standing on the passenger seat of her dad’s car as a toddler, wearing a peach-colored blouse, while he drove from their Kentucky home to Florida to pick up drugs. On a stop…
Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees
Sen. Ron Wyden and 14 Democratic co-sponsors plan to introduce legislation Thursday to cap consumers’ potential out-of-pocket costs in traditional Medicare, resurfacing a long-running debate over why the program doesn’t limit beneficiary spending. Even the bill’s backers say securing passage this year is a long shot. But the effort is one more opportunity for Democrats…
How The Patient Rights Revolution Builds on America’s 1776 One
By MICHAEL MILLENSON It took 129 years for the inalienable rights proclaimed in America’s Declaration of Independence to apply to the rights of patients in relationship to their doctors. In 1905, an Illinois appellate court ruled in favor of a woman who’d sued her surgeon for performing a hysterectomy without disclosing in advance what procedure…
New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast Cancer
Gilead Sciences antibody drug conjugate Trodelvy is now approved as a first-line treatment for triple-negative breast cancer. This expanded approval for Trodelvy comes with a slightly broader label that gives it an edge over the AstraZeneca and Daiichi Sankyo ADC Datroway. The post New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in…
New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases
Priority Health is partnering with Garner Health to steer members to high-quality physicians and reduce healthcare costs for employers. The post New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases appeared first on MedCity News.
Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t
Women’s health platform Xella Health launched with a $499-per-year membership. The platform provides women the kind of connected healthcare that has typically only been available through expensive concierge medicine, said CEO Kelly Lacob. The post Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t appeared first on MedCity News.
Protected: How Unaffordable is Health Care? A Short Video Series from KFF
There is no excerpt because this is a protected post.
Protected: Video: Health Care Affordability at the Macro Level
There is no excerpt because this is a protected post.
How Foreign Reference Pricing Embeds Valuations And Risks Undermining Global Innovation
That is the title of my new Health Affairs Forefront piece out today with Lou Garrison and Richard Xie. An excerpt from the article is below: United States policy makers increasingly argue that Americans pay too much for prescription drugs. In a recent report, the Senate Health, Education, Labor, and Pensions (HELP) Committee minority staff contended…
